Concepedia

Masanori Oshi

MO

76

Publications

3.6K

Citations

37

H-Index

2017

Active since

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Yokohama City University

Tokyo Medical University

Niigata University

University at Buffalo, State University of New York

Masanori Oshi is an author at Roswell Park Comprehensive Cancer Center specializing in medicine, tumor biology, and oncology.

ORCID

Top concepts

Publications per year

2017–2024

76

Publications

76

CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer

Masanori Oshi, Mariko Asaoka, Yoshihisa Tokumaru et al. · International Journal of Molecular Sciences · 2020 · 213 citations · Full text

M1 Macrophage and M1/M2 ratio defined by transcriptomic signatures resemble only part of their conventional clinical characteristics in breast cancer

Masanori Oshi, Yoshihisa Tokumaru, Mariko Asaoka et al. · Scientific Reports · 2020 · 212 citations · Full text

G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer

Masanori Oshi, Hideo Takahashi, Yoshihisa Tokumaru et al. · International Journal of Molecular Sciences · 2020 · 162 citations · Full text

, , +12

The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2− Breast Cancer

Masanori Oshi, Hideo Takahashi, Yoshihisa Tokumaru et al. · Cells · 2020 · 130 citations · Full text

, , +17

MYC Targets Scores Are Associated with Cancer Aggressiveness and Poor Survival in ER-Positive Primary and Metastatic Breast Cancer

Amy K. Schulze, Masanori Oshi, Itaru Endo et al. · International Journal of Molecular Sciences · 2020 · 127 citations · Full text

Rows per page

1–5 of 76